Literature DB >> 26301054

Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?

Mercedes Amieva-Balmori1, Scherezada María Isabel Mejia-Loza1, Roberto Ramos-González1, Felipe Zamarripa-Dorsey1, Eli García-Ruiz1, Nuria Pérez Y López1, Eumir I Juárez-Valdés1, Adriana López-Luria1, José María Remes-Troche1.   

Abstract

AIM: To compare the ability of model for end-stage liver disease (MELD)-Na and Maddrey discrimination function index (DFI) to predict mortality at 30 and 90 d in patients with alcoholic hepatitis (AH).
METHODS: We prospectively assessed 52 patients with AH. Demographic, clinical and laboratory parameters were obtained. MELD-Na and Maddrey DFI were calculated on admission. Short-term mortality was assessed at 30 and 90 d. Receiver operating characteristic curve analysis was performed.
RESULTS: Thirty-day and 90-d mortality was 44% and 58%, respectively. In the univariate analysis, sodium levels was associated with mortality at 30 and 90 d (P = 0.001 and P = 0.03). Child stage, encephalopathy, ascites, or types of treatment were not associated with mortality. MELD-Na was the only predictive factor for mortality at 90 d. For 30-d mortality area under the curve (AUC) was 0.763 (95%CI: 0.63-0.89) for Maddrey DFI and 0.784 for MELD-Na (95%CI: 0.65-0.91, P = 0.82). For 90-d mortality AUC was 0.685 (95%CI: 0.54-0.83) for Maddrey DFI and 0.8710 for MELD-Na (95%CI: 0.76-0.97, P = 0.041).
CONCLUSION: AH is associated with high short-term mortality. Our results show that MELD-Na is a more valuable model than DFI to predict short-term mortality.

Entities:  

Keywords:  Alcoholic hepatitis; Maddrey; Model for end-stage liver disease-Na; Mortality

Year:  2015        PMID: 26301054      PMCID: PMC4539405          DOI: 10.4254/wjh.v7.i17.2119

Source DB:  PubMed          Journal:  World J Hepatol


  40 in total

Review 1.  Alcoholic hepatitis.

Authors:  Michael R Lucey; Philippe Mathurin; Timothy R Morgan
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

Review 2.  Prevention and management of brain edema in patients with acute liver failure.

Authors:  Fin Stolze Larsen; Julia Wendon
Journal:  Liver Transpl       Date:  2008-10       Impact factor: 5.799

3.  Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis.

Authors:  H Orrego; J E Blake; L M Blendis; A Medline
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

4.  Histological changes in human liver biopsies from chronic alcoholics.

Authors:  P Christoffersen; K Nielsen
Journal:  Acta Pathol Microbiol Scand A       Date:  1972

5.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

Review 6.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

7.  A randomized trial of prednisolone in patients with severe alcoholic hepatitis.

Authors:  M J Ramond; T Poynard; B Rueff; P Mathurin; C Théodore; J C Chaput; J P Benhamou
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

8.  Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.

Authors:  Adnan Said; John Williams; Jeremy Holden; Patrick Remington; Ronald Gangnon; Alexandru Musat; Michael R Lucey
Journal:  J Hepatol       Date:  2004-06       Impact factor: 25.083

9.  A new scoring system for prognostic stratification of patients with alcoholic hepatitis.

Authors:  Marlene Dominguez; Diego Rincón; Juan G Abraldes; Rosa Miquel; Jordi Colmenero; Pablo Bellot; Joan-Carles García-Pagán; Rosamelia Fernández; Montserrat Moreno; Rafael Bañares; Vicente Arroyo; Joan Caballería; Pere Ginès; Ramón Bataller
Journal:  Am J Gastroenterol       Date:  2008-08-21       Impact factor: 10.864

10.  Liver transplantation for autoimmune hepatitis: a single-center experience.

Authors:  H Khalaf; W Mourad; Y El-Sheikh; A Abdo; A Helmy; Y Medhat; M Al-Sofayan; M Al-Sagheir; M Al-Sebayel
Journal:  Transplant Proc       Date:  2007-05       Impact factor: 1.066

View more
  2 in total

Review 1.  Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise.

Authors:  G Liamis; T D Filippatos; A Liontos; M S Elisaf
Journal:  Hepatol Int       Date:  2016-06-21       Impact factor: 6.047

Review 2.  Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Authors:  Khushboo S Gala; Vatsalya Vatsalya
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.